Navigation Links
MedImmune Initiates First Clinical Trial of Monoclonal Antibody Targeting GM-CSFR in Patients with Rheumatoid Arthritis
Date:11/26/2007

isease.

About MedImmune's Anti-GM-CSFR Antibody Development Program

In 2001, MedImmune's Cambridge facility (then known as Cambridge Antibody Technology) and AMRAD Operations Pty Ltd., now owned by CSL Limited, entered into a collaboration to jointly discover and develop human MAb therapeutics that neutralize the GM-CSF receptor, including CAM-3001. Under the terms of a subsequent licensing agreement entered into in August 2007, CSL will receive upfront and milestone payments, as well as royalties, on future sales of CAM- 3001. Additional terms of the agreement have not been disclosed.

About Rheumatoid Arthritis

Rheumatoid arthritis is a chronic systemic inflammatory disease that is associated with significant morbidity and mortality. The disease is characterized by inflammation of the synovial joints that can result in pain, swelling and joint damage with secondary deformity and progressive disability. Despite current treatment options, there is a significant mortality associated with RA, especially the more severe forms of the disease. There is need for additional treatments to control moderate to severely active disease. A new treatment is needed that may provide a significant clinical benefit for disease remission, as well as inhibiting progressive joint damage, and improving quality of life in patients with RA.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is dedicated to advancing science and medicine to help people live better lives and is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.


'/>"/>
SOURCE MedImmune Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
2. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
3. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
4. MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
5. MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV
6. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
7. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
8. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
11. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 By now, if you haven,t heard ... on this planet. The awareness campaign has brought this devastating ... to raise over $88.5 Million (and counting) for ALS. Every ... companies are starting to as well. One such ... , who actually works with ALS sufferers and helps ...
(Date:8/27/2014)... , August 27, 2014 ResearchMoz ... States  Laparoscopes Market Outlook to 2020. New report, ... market data on the United States Laparoscopes market ... dollars, volume (in units) and average prices (in US ... Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... available in its catalogue: Baby Food Eastern ... Summary "Baby Food Eastern Europe 2014" is a ... industry demand prospects in Eastern Europe ... on various trends. This report also examines trends which ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5Baby Food Eastern Europe 2014 2Baby Food Eastern Europe 2014 3Baby Food Eastern Europe 2014 4Baby Food Eastern Europe 2014 5Baby Food Eastern Europe 2014 6Baby Food Eastern Europe 2014 7Baby Food Eastern Europe 2014 8
... April 10 Nektar Therapeutics,(Nasdaq: NKTR ... clinical,results for its pipeline programs will be ... the coming months. These presentations will,highlight Nektar,s ... oncology,anti-infectives and central nervous system (CNS), which ...
... April 9, 2008 New devices and research ... Institutes,of Health (NIH) National Heart, Lung, and Blood ... at the International Society,for Heart and Lung Transplantation ... is ongoing this week at the Boston,Marriott Copley ...
Cached Medicine Technology:Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 2Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 3Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings 4New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2
(Date:8/27/2014)... August 27, 2014 Parker Waichman LLP, ... rights of victims injured by defective medical devices, reports ... for discovery procedures, specifically Collection and Preservation of Evidence, ... transvaginal mesh devices. (MDL No. 2187, In Re: C.R. ... United States District Court, Southern District or West Virginia; ...
(Date:8/27/2014)... 27, 2014 Ticket Down is a dependable ... Sun Life Stadium in Miami. The Brazilian national soccer ... September 5 at Sun Life Stadium in Miami Gardens, Florida. ... rematch of the World Cup earlier this year when Brazil ... injury. The Brazilian Soccer Federation announced earlier this week that ...
(Date:8/27/2014)... Lee Antimicrobial Solutions LLC (“LAMS”), ... Technology and a Leader in Environmental Disinfection Device ... a device developed for home use available for ... unveiled DHP Technology, a revolutionary means to disinfect ... of bacteria, viruses, microbes and offensive odors. A ...
(Date:8/27/2014)... UK (PRWEB) August 27, 2014 ... through a period of dramatic changes. The country’s ... supervision and administration of medical equipment are far ... economy over the past 30 years. Chinese state ... and Administration of Medical Devices” to try to ...
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
Breaking Medicine News(10 mins):Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 2Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 3Health News:New Discovery Rules Have Been Put in Place by the Court Overseeing C.R. Bard Transvaginal Mesh Litigation, Parker Waichman LLP Comments 4Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 2Health News:Brazil vs. Colombia Tickets in Miami, FL: Ticket Down Cuts Ticket Prices on World Cup Rematch of Colombia vs. Brazil at Sun Life Stadium in Miami on Sept. 5th 3Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 2Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 3Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 2Health News:Chinese Regulations for Imported Medical Device Registration Discussed by Access China in New Research Report Published at MarketPublishers.com 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4
... Scientists are reporting development and successful initial laboratory tests ... help individuals addicted to heroin abstain from the illicit ... Medicinal Chemistry . Kim D. Janda and colleagues ... than $22 billion in 1996 annually due to medical ...
... 20 (HealthDay News) -- Inherited forms of Alzheimer,s disease ... with memory and thinking develop, according to new research. ... dementia symptoms appear, the disease has severely damaged the ... mental abilities or memories, the study authors noted. ...
... (ROME, 20 July 2011) Bristol-Myers Squibb Company ... study, which included 1,294 antiretroviral (ARV)-experienced patients (336 ... Sweden, that were presented today at the Sixth ... and Prevention (IAS 2011). In a gender-specific ...
... disease, a rare hereditary condition where abnormal fatty deposits collect ... react differently to those in other European countries, according to ... International Journal of Clinical Practice . Researchers from ... different pattern of organ involvement in ill health and death ...
... the University of Liverpool has found that babies admitted to ... are twice as likely to need oxygen therapy and five ... parents do not smoke. The study assessed infants from ... a diagnosis of bronchiolitis. The city has many areas ...
... Reporter , TUESDAY, July 19 (HealthDay News) -- People with ... put themselves at a greater risk of having a heart ... a low dose (typically between 75 and 300 milligrams) is ... disease. Yet as many as 50 percent of patients stop ...
Cached Medicine News:Health News:Study: Inherited Alzheimer's Detectable 20 Years Before Symptom Onset 2Health News:In the real life setting, boosted REYATAZ proves as effective in women living with HIV as men 2Health News:Spanish Fabry disease patients appear to react differently to the rest of Europe 2Health News:Stopping Daily Aspirin Boosts Heart Attack Risk: Study 2Health News:Stopping Daily Aspirin Boosts Heart Attack Risk: Study 3
The S7 Elite is the premium device in ResMeds award-winning S7 series. All S7 devices include an option of integrated humidification....
... The S8 Elite is the premium CPAP device ... generators. The S8 line of flow generators are ... first flow generators to include an option of ... to the device for simplicity and convenience. Premium ...
... freedom and flexibility with the integrated ... battery pack, the system will be ... Also includes an integrated heated humidifier. ... water for one nights use, and ...
... The GoodKnight 420 CPAP System is ... pressure (CPAP) device on the market. It ... patients preserve their lifestyles while complying with ... to 600 sessions of date/time usage data. ...
Medicine Products: